Lifestyle Mitigates APOE ε4 Dementia Risk—Except for Homozygotes—Undermining Genetic Fatalism in Aging Prevention

The Kyushu University and RIKEN observational study of 9,605 Japanese adults aged 65+ demonstrates that favorable modifiable risk factors (mRFs) like blood pressure control and physical activity lower dementia incidence among APOE ε4 carriers with zero or one allele, aligning with reduced brain atrophy on MRI. However, homozygotes (two alleles) showed over 10-fold elevated risk unaffected by mRF scores, highlighting a critical threshold where genetics dominate. This observational cohort (not an RCT) builds on the Lancet Commission's 2020 report identifying 12 modifiable risks accounting for ~40% of dementia cases globally, yet extends it by stratifying genetic subgroups—a nuance often overlooked in broad prevention messaging. Sample size is robust but limited by self-reported lifestyle data and Japanese population specificity, with no declared conflicts. It connects to the FINGER RCT (2015, n=1,260), where multidomain interventions improved cognition even in at-risk groups, suggesting vascular and inflammatory pathways (e.g., hypertension-driven white matter lesions) offer leverage before extreme genetic loading. Mainstream coverage misses how socioeconomic patterns and early-life exposures amplify mRF effects across ancestries, while underplaying needs for pharmacogenomic trials in homozygotes. These findings reinforce population-level strategies targeting midlife vascular health to counter fatalism, but urge precision approaches beyond lifestyle for the ~2% of ε4 homozygotes.